In the Weeds? Humira “Patent Thicket” Isn’t an Antitrust Violation
By Alexandra Lewis on Aug 11, 2022
Posted In Antitrust, Patents
The US Court of Appeals for the Seventh Circuit affirmed that welfare benefit plans that bought the drug Humira did not have valid antitrust claims against the patent owner. The Court found that amassing patents by itself is not enough to give rise to an antitrust claim, and that the welfare benefit plans would need...